September 19, 2016

Longtime biomedical industry executive Martin Landon has been named chief executive officer of BioBridge Global (BBG), the nonprofit organization that oversees and supports the South Texas Blood & Tissue Center (STBTC), QualTex Laboratories, GenCure and The Blood & Tissue Center Foundation. The announcement was made today by BBG Board Chair Mike Kreager. 

Landon will join BBG on Oct. 1 and, to ensure a smooth leadership transition, will work with current CEO Linda Myers through the end of the month, Kreager said.  In July, Myers announced plans to retire from the organization.

Announcements